Search Results - "Calaway, Adam"

Increased risk of upper tract urothelial carcinoma in patients with kidney stones: a large-scale analysis of the UK biobank.

Authors: Ziadeh, Hachem Calaway, Adam Gupta, Sanjay et al.

Source: Urolithiasis. 5/7/2025, Vol. 53 Issue 1, p1-7. 7p.

Changing USA national trends for adrenalectomy: the influence of surgeon and technique.

Authors: Monn, M. Francesca Calaway, Adam C. Mellon, Matthew J. et al.

Source: BJU International. Feb2015, Vol. 115 Issue 2, p288-294. 7p.

Assessment of required nodal yield in a high risk cohort undergoing extended pelvic lymphadenectomy in robotic-assisted radical prostatectomy and its impact on functional outcomes.

Authors: Sagalovich, Daniel Calaway, Adam Srivastava, Abhishek et al.

Source: BJU International. Jan2013, Vol. 111 Issue 1, p85-94. 10p. 5 Color Photographs, 1 Diagram, 5 Charts.

Re: Robert Huddart, Shaista Hafeez, Clare Griffin, et al. Dose-escalated Adaptive Radiotherapy for Bladder Cancer: Results of the Phase 2 RAIDER Randomized Controlled Trial. Eur Urol 2025;87:60–70.

Authors: Davis, Laura E. Calaway, Adam Shoag, Jonathan

Source: European Urology. Apr2025, Vol. 87 Issue 4, pe73-e74. 2p.

Growth of the Twitter Presence of Academic Urology Training Programs and Its Catalysis by the COVID-19 Pandemic.

Authors: Manning, Emily Calaway, Adam Dubin, Justin M. et al.

Source: European Urology. Aug2021, Vol. 80 Issue 2, p261-263. 3p.

Improving postoperative quality of care in germ cell tumor patients: Does scheduled alvimopan, acetaminophen, and gabapentin improve short-term clinical outcomes after retroperitoneal lymph node dissection?

Authors: Calaway, Adam C. Foster, Richard S. Tong, Yan et al.

Source: Urologic Oncology. Apr2020, Vol. 38 Issue 4, p305-312. 8p.

Robot-Assisted Radical Prostatectomy in Patients with a History of Holmium Laser Enucleation of the Prostate: The Indiana University Experience.

Authors: Abedali, Zain A. Calaway, Adam C. Large, Tim et al.

Source: Journal of Endourology. Feb2020, Vol. 34 Issue 2, p163-168. 6p.

Recent Advances in Immunotherapy for Non-Muscle-Invasive Bladder Cancer.

Authors: Grier, Abby L. Zhong, Jeffrey Y. Basourakos, Spyridon et al.

Source: Cancers. Feb2026, Vol. 18 Issue 4, p623. 21p.

BLADDER CANCER SUSCEPTIBILITY: UNVEILING MODIFIABLE AND NON-MODIFIABLE RISK FACTORS.

Authors: Parekh, Sneha Calaway, Adam Davis, Laura et al.

Source: Urologic Oncology. Mar2024:Supplement, Vol. 42, pS38-S39. 2p.

Oncologic Outcomes Following Surgical Management of Clinical Stage II Sex Cord Stromal Tumors.

Authors: Calaway, Adam C. Tachibana, Isamu Masterson, Timothy A. et al.

Source: Urology. May2019, Vol. 127, p74-79. 6p.

Evaluating the impact of minimally invasive vs open trials in urologic malignancy. Are we missing the mark?

Authors: Boris, Ronald S Calaway, Adam C

Source: Urologic Oncology. Aug2020, Vol. 38 Issue 8, p643-645. 3p.

Re: Nima Nassiri, Giovanni Cacciamani, Inderbir S. Gill. Robotic Bladder Auto-transplantation in a Heart-beating Brain-dead Human Research Donor. Eur Urol. 2023;84:517–518.

Authors: Davis, Laura E. Calaway, Adam Bukavina, Laura

Source: European Urology. Nov2023, Vol. 84 Issue 5, pe119-e120. 2p.

Adverse Surgical Outcomes Associated with Robotic Retroperitoneal Lymph Node Dissection Among Patients with Testicular Cancer.

Authors: Calaway, Adam C. Einhorn, Lawrence H. Masterson, Timothy A. et al.

Source: European Urology. Nov2019, Vol. 76 Issue 5, p607-609. 3p.

Anatomic comparison of traditional and enucleation partial nephrectomy specimens.

Authors: Calaway, Adam C. Gondim, Dibson D. Flack, Chandra K. et al.

Source: Urologic Oncology. May2017, Vol. 35 Issue 5, p221-226. 6p.

GERMLINE VARIANTS LINKED TO OVARIAN AND BLADDER CANCER IN FEMALES: IS OVARY SPARING RADICAL CYSTECTOMY AN OPTION?

Authors: Davis, Laura Elizabeth Calaway, Adam Ponsky, Lee et al.

Source: Urologic Oncology. Mar2024:Supplement, Vol. 42, pS29-S29. 1p.

Definitive surgical therapy for refractory radiation cystitis: Evaluating effectiveness, tolerability, and extent of surgical approach.

Authors: Tachibana, Isamu Calaway, Adam C. Abedali, Zain et al.

Source: Urologic Oncology. Nov2021, Vol. 39 Issue 11, p789.e1-789.e7. 1p.

Circulating Tumor DNA To Assess Minimal Residual Disease: Versatile, but How Valuable?

Authors: Brown, Jason R. Sonpavde, Guru P. Calaway, Adam et al.

Source: European Urology. Oct2024, Vol. 86 Issue 4, p312-314. 3p.

Postchemotherapy retroperitoneal lymph node dissection in patients presenting with very high HCG levels.

Authors: Speir, Ryan W. Calaway, Adam C. Einhorn, Lawrence H. et al.

Source: Urologic Oncology. Aug2020, Vol. 38 Issue 8, p687.e19-687.e23. 1p.

Increasing Utilization of Sedation for Prostate Biopsies: National Trends, Predictors, and Patient Cost.

Authors: Arenas-Gallo, Camilo Goldman, Mollie Millot, Jack C. et al.

Source: Urology. Nov2025, Vol. 205, p112-118. 7p.

Comparing oncologic outcomes in patients undergoing surgery for oncocytic neoplasms, conventional oncocytoma, and chromophobe renal cell carcinoma.

Authors: Flack, Chandra K. Calaway, Adam C. Miller, Brady L. et al.

Source: Urologic Oncology. Nov2019, Vol. 37 Issue 11, p811.e17-811.e21. 1p.